Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs)

被引：0
|
作者：
Andrei, G
Sienaert, R
Naesens, L
De Clercq, E
McGuigan, C
Balzarini, J
Snoeck, R
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Wales Coll Cardiff, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
来源：
ANTIVIRAL RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
81
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Susceptibilities of several clinical Varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides
    Andrei, G
    Sienaert, R
    McGuigan, C
    De Clercq, E
    Balzarini, J
    Snoeck, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1081 - 1086
  • [2] Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of Varicella-Zoster virus (VZV)
    Sienaert, R
    Naesens, L
    Brancale, A
    Carangio, A
    Andrei, G
    Snoeck, R
    Van Kuilenburg, A
    De Clercq, E
    McGuigan, C
    Balzarini, J
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8): : 995 - 997
  • [3] Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication
    Balzarini, J
    McGuigan, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 5 - 9
  • [4] Interaction of the bicyclic nucleoside analogues (BCNAs) with human varicella-zoster virus (VZV) and simian varicella virus (SVV) thymidine kinase and VZV DNA polymerase
    Sienaert, R
    Naesens, L
    Luoni, G
    Wathen, M
    Gray, W
    Andrei, G
    Snoeck, R
    De Clercq, E
    McGuigan, C
    Balzarini, J
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A67 - A67
  • [5] Biochemical basis for the strong selectivity of bicyclic nucleoside analogues (BCNAs) as inhibitors of varicella-zoster virus
    Sienaert, R
    Naesens, L
    Brancale, A
    De Clercq, E
    McGuigan, C
    Balzarini, J
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A52 - A52
  • [6] Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base
    McGuigan, C
    Yarnold, CJ
    Jones, G
    Velázquez, S
    Barucki, H
    Brancale, A
    Andrei, G
    Snoeck, R
    De Clercq, E
    Balzarini, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4479 - 4484
  • [7] Although the bicyclic nucleoside analogues (BCNAs) are highly active against varicella-zoster virus (VZV), they are inactive against simian varicella virus (SVV) despite efficient phosphorylation of the BCNAs by SVV-encoded thymidine kinase
    Sienaert, R
    Andrei, G
    Snoeck, R
    De Clercq, E
    Luoni, G
    McGuigan, C
    Balzarini, J
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A65 - A65
  • [8] Pharmacological properties of the novel anti-varicella-zoster virus bicyclic nucleoside analogues (BCNAs)
    Balzarini, J
    Sienaert, R
    Naesens, L
    Andrei, G
    Snoeck, R
    Van Kuilenburg, A
    Brancale, A
    De Clercq, E
    McGuigan, C
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A52 - A52
  • [9] Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic nucleoside analogs (BCNAS).
    De Clercq, E
    Balzarini, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U8 - U8
  • [10] Bicyclic nucleoside inhibitors of Varicella-Zoster virus (VZV): The effect of terminal unsaturation in the side chain
    Srinivasan, S
    McGuigan, C
    Andrei, G
    Snoeck, R
    De Clercq, E
    Balzarini, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 391 - 393
12345